On October 23, 2019, Andrew G. Long informed the INSYS Therapeutics, Inc. that he will step down from his position as Chief Executive Officer of the Company and from all other positions he holds with the Company, and from the Board of Directors of the Company, effective November 8, 2019. The Company and the Board of Directors thank Mr. Long for his service and wish him the best in his next endeavors. The Company's senior management team and Board of Directors will continue to manage, oversee and wind down the Company's operations through the effective date of the Plan.